In Other News

• Blood-Based Epigenetic Signals Enable Osteosarcoma Disease Monitoring

• Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

• Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

• AI-Enabled Biochip Detects microRNA Biomarkers in Minutes

• QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026

• Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma

• Blood Test Detects Early Pancreatic Cancer in High-Risk Patients

• Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

• Tumor Analysis Identifies Protein Changes Driving Bispecific Resistance in Myeloma

• QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026

• Long-Read RNA Sequencing Platform Improves Rare Disease Diagnosis

• Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers

• Ultrasensitive Assay Reveals Previously Undetected Tuberculosis in Hospital Patients

• Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers

• Study Confirms Barrett’s Esophagus as Precursor to Esophageal Cancer

• AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer

• Collaboration Applies AI Pathology to Predict Response to Antibody-Drug Conjugates

• Syndromic Panel Enables Rapid Identification of Bloodstream Infections

• AI Tool Predicts Bevacizumab Non-Response in Metastatic Colorectal Cancer

• Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

• Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing

• Study Identifies Hidden B-Cell Mutations in Autoimmune Disease

• Biomarker Predicts Immunotherapy Response and Prognosis in Colorectal Cancer